1326 related articles for article (PubMed ID: 33272977)
1. Gut microbiota-derived metabolites as central regulators in metabolic disorders.
Agus A; Clément K; Sokol H
Gut; 2021 Jun; 70(6):1174-1182. PubMed ID: 33272977
[TBL] [Abstract][Full Text] [Related]
2. The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases.
Neves AL; Chilloux J; Sarafian MH; Rahim MB; Boulangé CL; Dumas ME
Curr Opin Pharmacol; 2015 Dec; 25():36-44. PubMed ID: 26531326
[TBL] [Abstract][Full Text] [Related]
3. Metabolites Linking the Gut Microbiome with Risk for Type 2 Diabetes.
Zhu T; Goodarzi MO
Curr Nutr Rep; 2020 Jun; 9(2):83-93. PubMed ID: 32157661
[TBL] [Abstract][Full Text] [Related]
4. Understanding connections and roles of gut microbiome in cardiovascular diseases.
Rajendiran E; Ramadass B; Ramprasath V
Can J Microbiol; 2021 Feb; 67(2):101-111. PubMed ID: 33079568
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease.
Lavelle A; Sokol H
Nat Rev Gastroenterol Hepatol; 2020 Apr; 17(4):223-237. PubMed ID: 32076145
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiota and Cardiovascular Disease.
Witkowski M; Weeks TL; Hazen SL
Circ Res; 2020 Jul; 127(4):553-570. PubMed ID: 32762536
[TBL] [Abstract][Full Text] [Related]
7. Dietary Fiber from Oat and Rye Brans Ameliorate Western Diet-Induced Body Weight Gain and Hepatic Inflammation by the Modulation of Short-Chain Fatty Acids, Bile Acids, and Tryptophan Metabolism.
Kundi ZM; Lee JC; Pihlajamäki J; Chan CB; Leung KS; So SSY; Nordlund E; Kolehmainen M; El-Nezami H
Mol Nutr Food Res; 2021 Jan; 65(1):e1900580. PubMed ID: 32526796
[TBL] [Abstract][Full Text] [Related]
8. Dietary lipids, gut microbiota and lipid metabolism.
Schoeler M; Caesar R
Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
[TBL] [Abstract][Full Text] [Related]
9. Microbial metabolites as modulators of host physiology.
Joyce SA; Clarke DJ
Adv Microb Physiol; 2024; 84():83-133. PubMed ID: 38821635
[TBL] [Abstract][Full Text] [Related]
10. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
11. Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease.
Masse KE; Lu VB
Front Endocrinol (Lausanne); 2023; 14():1169624. PubMed ID: 37560311
[TBL] [Abstract][Full Text] [Related]
12. Dietary Patterns Affect the Gut Microbiome-The Link to Risk of Cardiometabolic Diseases.
Tindall AM; Petersen KS; Kris-Etherton PM
J Nutr; 2018 Sep; 148(9):1402-1407. PubMed ID: 30184227
[TBL] [Abstract][Full Text] [Related]
13. The Gut Microbial Endocrine Organ in Type 2 Diabetes.
Massey W; Brown JM
Endocrinology; 2021 Feb; 162(2):. PubMed ID: 33373432
[TBL] [Abstract][Full Text] [Related]
14. Microbial Metabolites Determine Host Health and the Status of Some Diseases.
Sittipo P; Shim JW; Lee YK
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31653062
[TBL] [Abstract][Full Text] [Related]
15. The contribution of gut bacterial metabolites in the human immune signaling pathway of non-communicable diseases.
Hosseinkhani F; Heinken A; Thiele I; Lindenburg PW; Harms AC; Hankemeier T
Gut Microbes; 2021; 13(1):1-22. PubMed ID: 33590776
[TBL] [Abstract][Full Text] [Related]
16. Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites.
Ding Y; Yanagi K; Cheng C; Alaniz RC; Lee K; Jayaraman A
Pharmacol Res; 2019 Mar; 141():521-529. PubMed ID: 30660825
[TBL] [Abstract][Full Text] [Related]
17. Interactions between polysaccharides and gut microbiota: A metabolomic and microbial review.
Zhang D; Liu J; Cheng H; Wang H; Tan Y; Feng W; Peng C
Food Res Int; 2022 Oct; 160():111653. PubMed ID: 36076442
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.
Chen X; Zhang H; Ren S; Ding Y; Remex NS; Bhuiyan MS; Qu J; Tang X
Chin Med J (Engl); 2023 Oct; 136(19):2269-2284. PubMed ID: 37442759
[TBL] [Abstract][Full Text] [Related]
19. Bile acids as regulatory molecules and potential targets in metabolic diseases.
Xie AJ; Mai CT; Zhu YZ; Liu XC; Xie Y
Life Sci; 2021 Dec; 287():120152. PubMed ID: 34793769
[TBL] [Abstract][Full Text] [Related]
20. Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice.
Hu B; Ye C; Leung EL; Zhu L; Hu H; Zhang Z; Zheng J; Liu H
Pharmacol Res; 2020 Sep; 159():104942. PubMed ID: 32504835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]